Aldosterone antagonists in HF

Links shared publicly online about this topic.

  • 1,662
    total visits

Aldosterone antagonists in HF

theheart.org

Just one-third of hospitalized HF patients who meet the criteria for an aldosterone antagonist receive the drugs upon discharge. On the plus side, few patients with contraindications are prescribed the medication.

View full resource at theheart.org

Tags: Drug

  • Share

Most Recently Shared on October 20, 2009 at 8:18 pm By:

theheartorg Shelley Wood

heartwire: Just one-third of heart-failure patients receive aldosterone antagonists http://bit.ly/d0KnV

3 years ago...

Coalition Unveils Two Standards for Health Information Exchange - iHealthBeat

ihealthbeat.org — “A coalition of seven states and 11 health IT vendors has developed standard technical specifications for health information exchange. The standards are designed to facilitate data sharing and improve clinicians' ability to search for specific information. InformationWeek et al.View full resource at ihealthbeat.org

  • View Related
  • Share

Most Recently Shared on November 9, 2011 at 8:02 pm By:

iHealthBeat iHealthBeat.org Health Organization

Coalition Unveils Two Standards for Health Information Exchange - http://t.co/WZpryvKN

7 months ago...

U.S. Department of State

state.gov — “U.S. Department of StateView full resource at state.gov

  • View Related
  • Share

Most Recently Shared on November 7, 2011 at 6:22 pm By:

MSF_USA Doctors w/o Borders Health Organization

#SecClinton will present "a vision for turning the tide on HIV/AIDS." We'll be watching live at http://t.co/AbwPvugx #reverseAIDS

7 months ago...

New Data From Studies Bolsters Case For Using Aldosterone Antagonists In Heart Failure

medicalnewstoday.com — “Roughly 5 million people in the United States live with heart failure, a condition in which the heart is unable to pump blood around the body effectively. The causes and types of heart failure varView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 12:05 pm By:

mnt_cardiovasc MNT Cardiovascular Health News

New Data From Studies Bolsters Case For Using Aldosterone Antagonists In Heart Failure http://mnt.to/3ZLC #cardiovascular

8 months ago...

Aldosterone and aldosterone receptor antagonists in patients with chro

dovepress.com — “Peer reviewed article authored by (Nappi J, Sieg A). Read article or submit your manuscript for publishing.View full resource at dovepress.com

  • View Related
  • Share

Most Recently Shared on June 9, 2011 at 9:51 pm By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure. http://bit.ly/kspk58

12 months ago...

Symposier - Diuretic Prevents Atrial Arrhythmias in Heart Failure

symposier.com — “Uploaded and shared in Youtube by: MedPageToday — GOTHENBURG, Sweden -- The selective aldosterone-receptor blocker eplerenone (Inspra) reduces incidence of atrial fibrillation or flutter in mildly symptomatic systolic heart failure patients, according to an EMPHASIS-HF subanalysis.View full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 10:10 pm By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

Diuretic(eplerenone, Inspra) Prevents Atrial Arrhythmias in Heart Failure. http://bit.ly/jO8QvF

12 months ago...

Medical News: HFC: Diuretic Prevents Atrial Arrhythmias in HF - in Meeting Coverage, HFC from MedPage Today

medpagetoday.com — “GOTHENBURG, Sweden -- The selective aldosterone-receptor blocker eplerenone (Inspra) reduces incidence of atrial fibrillation or flutter in mildly symptomatic systolic heart failure patients, accordinView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 23, 2011 at 4:10 pm By:

Resultsfitness Tammi Jacobs Health Professional

HFC: Diuretic Prevents Atrial Arrhythmias in HF http://bit.ly/kyHNot

1 year ago...

Epleronone Shown To Reduce Atrial Fibrillation

medicalnewstoday.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 23, 2011 at 9:57 am By:

SpecialtyWisdom OrganizedWisdom OW Health

Epleronone Shown To Reduce Atrial Fibrillation: The aldosterone antagonist eplerenone (Inspra, Pfizer) significa... http://bit.ly/lSOiwQ

1 year ago...

Epleronone Shown To Reduce Atrial Fibrillation

medicalnewstoday.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 23, 2011 at 8:05 am By:

EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation

medicalxpress.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on May 22, 2011 at 4:59 pm By:

physorg_health PhysOrg Health News Health News

EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation http://tw.medicalxpress.com/225287940

1 year ago...

EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation

eurekalert.org — “The aldosterone antagonist eplerenone significantly reduced the development of new onset atrial fibrillation and flutter in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on May 22, 2011 at 3:55 pm By:

Resultsfitness Tammi Jacobs Health Professional

EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation http://bit.ly/lThVxt

1 year ago...

Gastroenterology Article | Liver Cirrhosis

mdlinx.com — “Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 10:46 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics ... http://bit.ly/lQmFRp #GI

1 year ago...

Symposier - AHA: Diuretic Cuts Morbidity, Mortality in Mild HF

symposier.com — “Uploaded and shared in Youtube by: MedPageToday --" CHICAGO -- Mildly symptomatic heart failure patients have better outcomes with the selective aldosterone-receptor blocker eplerenone (Inspra), a randomized controlled trial showed.View full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on December 6, 2010 at 6:23 pm By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

AHA: Diuretic Cuts Morbidity, Mortality in Mild Heart Failure. http://bit.ly/aZNON6

1 year ago...

Pulse - Aldosterone antagonists 'should be used routinely in heart failure'

pulsetoday.co.uk — “Pulse - Aldosterone antagonists 'should be used routinely in heart failure'View full resource at pulsetoday.co.uk

  • View Related
  • Share

Most Recently Shared on November 15, 2010 at 5:12 pm By:

pulsetoday PulseToday Health News and Medical Publisher

Aldosterone antagonists 'should be used routinely in heart failure': Patients with heart failure could benefit f... http://bit.ly/baepvo

2 years ago...

Medical News: AHA: Diuretic Cuts Morbidity, Mortality in Mild HF - in Meeting Coverage, AHA from MedPage Today

medpagetoday.com — “CHICAGO -- Mildly symptomatic heart failure patients have better outcomes with the selective aldosterone-receptor blocker eplerenone (Inspra), a randomized controlled trial showed.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on November 15, 2010 at 1:31 pm By:

AHA: Diuretic Cuts Morbidity, Mortality in Mild HF (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- CHICAGO --" Mildly symptomatic heart failure patients have better outcomes with the selective aldosterone-receptor blocker eplerenone (Inspra), a randomized controlled trial showed.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on November 14, 2010 at 3:47 pm By:

MedicalFeed MedicalFeed Health News Feed

AHA: Diuretic Cuts Morbidity, Mortality in Mild HF (CME/CE): (MedPage Today) -- CHICAGO — Mildly symptomatic hea... http://bit.ly/9EEQou

2 years ago...

Advertisement